XTL Biopharmaceuticals Ltd.

XTLB | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.38

-$0.02 (-0.83%)

At close: Sep 21, 2026, 4:00 PM ET

$2.22

-$0.16 (-6.72%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	76K	371K	1.4M	2.09M	2.97M	3.63M
Short-Term Investments	68K	772K	605K	1.63M	3.16M	2.41M
Long-Term Investments	n/a	14K	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	99K	29K	71K	94K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	22K	47K	-18K	-57K	-78K	13K
Total Current Assets	166K	1.34M	2.05M	3.81M	6.24M	6.12M
Property-Plant & Equipment	n/a	187K	n/a	n/a	1K	2K
Goodwill & Intangibles	n/a	7.01M	380K	380K	380K	380K
Total Long-Term Assets	n/a	7.21M	380K	380K	381K	382K
Total Assets	166K	8.55M	2.43M	4.19M	6.62M	6.5M
Account Payables	20K	196K	1K	2K	2K	2K
Deferred Revenue	n/a	18K	n/a	n/a	n/a	n/a
Short-Term Debt	269K	138K	n/a	n/a	n/a	n/a
Other Current Liabilities	2K	1.33M	n/a	n/a	n/a	n/a
Total Current Liabilities	420K	2.21M	206K	187K	231K	254K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	689K	n/a	n/a	1.05M	2.64M
Total Long-Term Liabilities	n/a	908K	n/a	n/a	1.05M	2.64M
Total Liabilities	420K	3.12M	206K	187K	1.29M	254K
Total Debt	269K	138K	n/a	n/a	n/a	n/a
Book Value	-254K	5.44M	2.22M	4M	5.33M	6.25M
Book Value Per Share	-0.58	12.35	6.52	11.74	13.86	19.44
Common Stock	25.14M	23.14M	14.12M	14.12M	14.12M	13.18M
Retained Earnings	-165.63M	-159.01M	-158.25M	-156.47M	-155.13M	-155.61M
Comprehensive Income	20K	20K	20K	20K	20K	20K
Shareholders Equity	-254K	5.44M	2.22M	4M	5.33M	3.61M
Total Investments	68K	786K	605K	1.63M	3.16M	2.41M